Genoox, an AI-driven genomic data interpretation software firm, was acquired for $70M by preclinical-stage biotechnology company QIAGEN to add next-generation sequencing (NGS) data analysis capabilities to support clinical decision-making.
Seller Name
Genoox
Buyer Name
Qiagen


Deal Value
$70M
Link
Value Type
Featured Category